Factor IX deficiency (Christmas disease).
作者信息
Philip J, Sarkar R S, Kumar S, Prathip B R, Pathak Amardeep
机构信息
Associate Professor, Department of Transfusion Medicine, AFMC, Pune 40, India.
Commandant, 151 Base Hospital, C/o 99 APO, India.
出版信息
Med J Armed Forces India. 2012 Oct;68(4):379-80. doi: 10.1016/j.mjafi.2011.12.007. Epub 2012 Aug 15.
Abstract
摘要
相似文献
1
Factor IX deficiency (Christmas disease).因子IX缺乏症（克里斯马斯病）。
Med J Armed Forces India. 2012 Oct;68(4):379-80. doi: 10.1016/j.mjafi.2011.12.007. Epub 2012 Aug 15.
2
[Hemophilia B; two cases of hereditary hemophilia due to a deficiency of a new clotting factor (Christmas factor)].
Acta Haematol. 1953 Aug;10(2):64-76.
3
[Hemophilia B; two familial case of blood disease due to deficiency of a new coagulation factor, Christmas factor].
Helv Paediatr Acta. 1953 Jun;8(3):185-201.
4
Deletion of Coagulation Factor IX Compromises Bone Mass and Strength: Murine Model of Hemophilia B (Christmas Disease).凝血因子 IX 缺失会损害骨量和骨强度：血友病 B（Christmas 病）的小鼠模型。
Calcif Tissue Int. 2021 Nov;109(5):577-585. doi: 10.1007/s00223-021-00872-x. Epub 2021 Jun 12.
5
Somatic mosaicism and female-to-female transmission in a kindred with hemophilia B (factor IX deficiency).乙型血友病（因子IX缺乏症）家系中的体细胞镶嵌现象及女性间传播
Proc Natl Acad Sci U S A. 1991 Jan 1;88(1):39-42. doi: 10.1073/pnas.88.1.39.
6
A method of assaying Christmas factor; its application to the study of Christmas disease (factor-ix deficiency).一种测定克里斯马斯因子的方法；其在克里斯马斯病（因子IX缺乏症）研究中的应用。
Br J Haematol. 1959 Oct;5:396-412. doi: 10.1111/j.1365-2141.1959.tb04050.x.
7
An investigation of three patients with Christmas disease due to an abnormal type of factor IX.对三名因异常类型的凝血因子IX导致患克里斯马斯病的患者进行的调查。
J Clin Pathol. 1968 Mar;21(2):160-5. doi: 10.1136/jcp.21.2.160.
8
Spontaneous disappearance of an IgA anti-factor IX inhibitor in a child with Christmas disease.一名患有克里斯马斯病的儿童体内IgA抗因子IX抑制剂的自发消失
Am J Hematol. 1984 Oct;17(3):321-5. doi: 10.1002/ajh.2830170312.
9
Subperiosteal orbital hemorrhage as initial manifestation of Christmas disease (factor IX deficiency).
Am J Ophthalmol. 2002 Apr;133(4):584-5. doi: 10.1016/s0002-9394(01)01409-x.
10
A naturally occurring inhibitor of Christmas factor (factor IX).一种天然存在的圣诞因子（因子IX）抑制剂。
Thromb Diath Haemorrh. 1962 Oct 1;8:67-81.
引用本文的文献
1
Emicizumab as a Promising Form of Therapy for Type A Hemophilia - A Review of Current Knowledge from Clinical Trials.依库珠单抗作为 A 型血友病的一种有前景的治疗形式——来自临床试验的现有知识综述。
Curr Protein Pept Sci. 2024;25(9):719-737. doi: 10.2174/0113892037294674240509094418.
2
Impact of Replacement Therapy on Pregnancy Outcomes in Hemophilia Carriers: A Historical Cohort Study in Saudi Arabia.替代疗法对血友病携带者妊娠结局的影响：沙特阿拉伯的一项历史性队列研究
Life (Basel). 2024 May 11;14(5):623. doi: 10.3390/life14050623.
3
Mutation detection and inhibitor risk in Iranian patients with Hemophilia A: Six novel mutations.伊朗甲型血友病患者的突变检测与抑制剂风险：六个新突变
Clin Case Rep. 2020 Sep 15;8(12):2976-2985. doi: 10.1002/ccr3.3294. eCollection 2020 Dec.
4
The impact of severe haemophilia and the presence of target joints on health-related quality-of-life.重度血友病和靶关节对健康相关生活质量的影响。
Health Qual Life Outcomes. 2018 May 2;16(1):84. doi: 10.1186/s12955-018-0908-9.
本文引用的文献
1
Recessively inherited coagulation disorders.隐性遗传凝血障碍。
Blood. 2004 Sep 1;104(5):1243-52. doi: 10.1182/blood-2004-02-0595. Epub 2004 May 11.
2
A cell-based model of coagulation and the role of factor VIIa.基于细胞的凝血模型及凝血因子VIIa的作用。
Blood Rev. 2003 Sep;17 Suppl 1:S1-5. doi: 10.1016/s0268-960x(03)90000-2.
3
Pharmacologic agents in the management of bleeding disorders.用于出血性疾病治疗的药物制剂。
Transfusion. 1990 Jul-Aug;30(6):541-51. doi: 10.1046/j.1537-2995.1990.30690333487.x.
Zotero 插件